News articles about National Health Investors (NYSE:NHI) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. National Health Investors earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the real estate investment trust an impact score of 47.5321483092495 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the media headlines that may have effected Accern’s analysis:
- National Health Investors (NHI) Reports Acquisition of 121-Bed Skilled Nursing Facility in Waxahachie, Texas for $14.4M (streetinsider.com)
- NHI Purchases New SNF in Texas for $14.4 Million (finance.yahoo.com)
- 7 REIT Payouts Getting Set To Grow In February (finance.yahoo.com)
- Stephens Analysts Give National Health Investors (NHI) a $79.00 Price Target (americanbankingnews.com)
A number of research analysts recently issued reports on NHI shares. BMO Capital Markets reaffirmed a “hold” rating and set a $80.00 target price on shares of National Health Investors in a report on Wednesday, October 18th. Zacks Investment Research cut National Health Investors from a “buy” rating to a “hold” rating in a research note on Friday, September 22nd. Stifel Nicolaus reissued a “buy” rating and issued a $82.00 price target on shares of National Health Investors in a research note on Wednesday, October 4th. SunTrust Banks assumed coverage on National Health Investors in a research note on Tuesday, October 10th. They issued a “hold” rating and a $80.00 price target on the stock. Finally, KeyCorp reissued an “underweight” rating on shares of National Health Investors in a research note on Tuesday, December 19th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $80.00.
National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, November 8th. The real estate investment trust reported $0.94 EPS for the quarter, missing the Zacks’ consensus estimate of $1.34 by ($0.40). National Health Investors had a return on equity of 12.74% and a net margin of 59.70%. equities analysts predict that National Health Investors will post 5.26 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Friday, December 29th will be given a dividend of $0.95 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $3.80 dividend on an annualized basis and a yield of 5.35%. National Health Investors’s payout ratio is presently 95.00%.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.